We are pleased to announce that the Committee for Medicinal Products for Veterinary Use (CVMP) has...
September 2021
Innovation - New light therapy supports skin recovery in pets
For faster skin recovery in dogs and cats, Vetoquinol has just introduced mid-May in the first...
June 2021
Q1 2021 SALES: €128M (UP 28% AT CONSTANT EXCHANGE RATES, UP 24% AS REPORTED) Q1 2021 ESSENTIALS...
April 2021
2020 sales: €427.5m (up 8.0% as reported) EBIT before depreciation of assets arising from...
March 2021
Vetoquinol wins the animal pharm’s award for best european company 2020
February 8 th, 2021 (Lure, France) - Vetoquinol announced today it has been awarded “Best European...
February 2021
Vetoquinol acquires the rights for Profender® from Elanco animal health for Canada
February 8th, 2021 (Lure, France) - Vetoquinol announced today the acquisition of the Canadian...
February 2021
Vetoquinol CEO Matthieu Frechin said: “ 2020 was an exceptional year on a number of counts. Above...
January 2021
Orion Animal Health and Vetoquinol expand collaboration
Orion Animal Health and Vetoquinol expand collaboration - Vetoquinol to distribute Orion’s Clevor®...
January 2021
